Menu

vTv Therapeutics Inc. VTVT

Full chart Compare
Set alert

Price alert · VTVT

All alert types
21.42 USD +0.24 (+1.11%)

Nov 10, 2026, 12:05 PM EST

21.42 Day range 22.64
20.56 52-week range 44.00
YTD
-46.45%
1 year
-23.49%

Revenue & Expenses

Other Income → Expenses: $5.82MExpenses → Selling, General & Admin: $13.65MExpenses → Research & Development: $11.55MExpenses → Income Tax: $100.00KGross Profit → Expenses: $1.02MRevenue → Gross Profit: $1.02MNet Loss → Expenses: $18.46MOther Income$5.82MGross Profit$1.02MNet Loss$18.46MExpenses$25.30MSelling, General & Admin$13.65MResearch & Development$11.55MIncome Tax$100.00KRevenue$1.02M

Latest period ending Dec 31, 2025 · select a line to chart its full history

VTVT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-32.81M-24.18M-25.50M-22.54M-20.05M
-26.97M-18.46M-20.25M-19.16M-12.99M
-3.20-3.20-9.71-9.98-8.29
VTVT annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
88.93M36.75M9.45M12.13M13.41M
89.90M38.27M11.02M33.24M25.47M
25.46M23.96M29.57M27.40M10.25M
64.44M12.20M-24.68M-10.74M-9.74M
VTVT annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-25.25M-25.31M-19.08M-16.02M-19.31M
77.44M52.61M12.00M14.75M26.98M
52.19M27.30M-2.68M-1.29M7.67M